Literature DB >> 10478632

Interactions between AT1 and AT2 receptors in uterine arteries from pregnant ewes.

J R McMullen1, K J Gibson, E R Lumbers, J H Burrell, J Wu.   

Abstract

This study was performed to investigate the roles of angiotensin receptors (AT1 and AT2) in the contractility of uterine arteries during normal pregnancy and after angiotensin II levels have been elevated. Pregnant ewes were given intravenous infusions of saline for 24 h (control) or angiotensin II (30 ng kg(-1) min(-1)) for 2 or 24 h. The contractile responses of uterine arterial rings to angiotensin II (4 microM) and antagonists were then examined in vitro. Most uterine arteries were relatively insensitive to the vasoconstrictor effects of angiotensin II. In rings from control ewes an angiotensin AT2 antagonist enhanced (P < 0.05) the contractile responses to angiotensin II, suggesting that angiotensin AT2 receptors inhibited the angiotensin AT1 receptor mediated contractions. Uterine arterial rings from ewes given intravenous infusions of angiotensin II displayed greater (P < 0.05) contractile responses to angiotensin II in vitro compared to rings from control ewes. This was in part due to down regulation of angiotensin AT2 receptors. Surprisingly, while performing these experiments a small number of ewes had uterine arteries which were "hyperreactive" to angiotensin II (contractile responses 6-fold greater). These ewes also had abnormal renin angiotensin systems and had some features which are characteristic of those seen in preeclampsia. The "hyperreactivity" of these arteries could only in part be explained by down regulation of angiotensin AT2 receptors. It is concluded that in normal pregnancy angiotensin AT2 receptors play a role in maintaining an adequate uterine blood flow for the fetus. When angiotensin II levels are elevated for a prolonged period this protective effect is lost partly because angiotensin AT1 receptors are down regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478632     DOI: 10.1016/s0014-2999(99)00454-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

2.  Defining the differential sensitivity to norepinephrine and angiotensin II in the ovine uterine vasculature.

Authors:  Charles R Rosenfeld; Kevin DeSpain; Xiao-tie Liu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

3.  Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies.

Authors:  Atsushi Miyamoto; Ryoko Wada; Aya Inoue; Shigeru Ishiguro; James K Liao; Akira Nishio
Journal:  Life Sci       Date:  2005-10-11       Impact factor: 5.037

4.  Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries.

Authors:  Vijayakumar Chinnathambi; Chellakkan S Blesson; Kathleen L Vincent; George R Saade; Gary D Hankins; Chandra Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2014-05-19       Impact factor: 10.190

5.  Differential sensitivity to angiotensin II and norepinephrine in human uterine arteries.

Authors:  Charles R Rosenfeld; Kevin DeSpain; R Ann Word; Xiao-tie Liu
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

6.  Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity.

Authors:  Liliya M Yamaleyeva; Victor M Pulgar; Sarah H Lindsey; Larissa Yamane; Jasmina Varagic; Carolynne McGee; Mauro daSilva; Paula Lopes Bonfa; Susan B Gurley; K Bridget Brosnihan
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-12       Impact factor: 4.310

Review 7.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 8.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

9.  Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide.

Authors:  Ruth E Hannan; Elizabeth A Davis; Robert E Widdop
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.